Morgan Stanley Analysts Give Fresenius Medical Care AG & Co. KGaA (FME) a €93.00 Price Target

Morgan Stanley set a €93.00 ($108.14) target price on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a research report sent to investors on Wednesday. The firm currently has a neutral rating on the stock.

A number of other research firms also recently weighed in on FME. Jefferies Financial Group set a €82.00 ($95.35) target price on Fresenius Medical Care AG & Co. KGaA and gave the stock a neutral rating in a research report on Monday, October 1st. JPMorgan Chase & Co. set a €97.90 ($113.84) target price on Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a research report on Wednesday, August 29th. Goldman Sachs Group set a €98.00 ($113.95) target price on Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a research report on Monday, October 1st. Sanford C. Bernstein set a €107.00 ($124.42) target price on Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a research report on Monday, October 1st. Finally, Deutsche Bank set a €107.00 ($124.42) target price on Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a research report on Friday, October 5th. Eight equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. The stock currently has an average rating of Buy and an average price target of €90.14 ($104.82).

FME opened at €70.82 ($82.35) on Wednesday. Fresenius Medical Care AG & Co. KGaA has a 1-year low of €75.53 ($87.83) and a 1-year high of €93.82 ($109.09).

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the U.S.

Featured Article: Capital gains and your 401(k) or IRA

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply